Clarivate Plc (NYSE:CLVT – Get Free Report) has earned an average rating of “Hold” from the eight ratings firms that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $7.75.
Several equities research analysts have recently issued reports on the stock. Barclays dropped their price objective on shares of Clarivate from $6.00 to $5.00 and set an “underweight” rating for the company in a research report on Wednesday, August 7th. Royal Bank of Canada lowered their price target on Clarivate from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Wednesday, August 7th.
View Our Latest Analysis on Clarivate
Insider Buying and Selling
Hedge Funds Weigh In On Clarivate
A number of hedge funds have recently bought and sold shares of CLVT. Exor N.V. lifted its holdings in Clarivate by 2.4% during the 1st quarter. Exor N.V. now owns 67,294,884 shares of the company’s stock worth $500,001,000 after buying an additional 1,566,519 shares during the last quarter. Baupost Group LLC MA raised its position in shares of Clarivate by 27.2% during the 2nd quarter. Baupost Group LLC MA now owns 38,929,635 shares of the company’s stock valued at $221,510,000 after acquiring an additional 8,331,233 shares in the last quarter. Impactive Capital LP lifted its stake in Clarivate by 0.3% during the first quarter. Impactive Capital LP now owns 37,887,185 shares of the company’s stock worth $281,502,000 after purchasing an additional 109,247 shares during the last quarter. Glenview Capital Management LLC boosted its holdings in Clarivate by 22.2% in the fourth quarter. Glenview Capital Management LLC now owns 24,651,047 shares of the company’s stock worth $228,269,000 after purchasing an additional 4,472,302 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Clarivate by 19.5% during the second quarter. Dimensional Fund Advisors LP now owns 14,752,994 shares of the company’s stock worth $83,945,000 after purchasing an additional 2,409,470 shares during the period. 85.72% of the stock is currently owned by institutional investors and hedge funds.
Clarivate Price Performance
CLVT stock opened at $6.94 on Friday. The company has a market cap of $4.64 billion, a PE ratio of -4.18, a price-to-earnings-growth ratio of 3.24 and a beta of 1.17. The company has a current ratio of 0.90, a quick ratio of 0.90 and a debt-to-equity ratio of 0.83. The stock has a 50-day moving average price of $6.47 and a two-hundred day moving average price of $6.45. Clarivate has a 12-month low of $4.97 and a 12-month high of $9.60.
Clarivate (NYSE:CLVT – Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.02. Clarivate had a negative net margin of 46.53% and a positive return on equity of 10.01%. The firm had revenue of $650.30 million during the quarter, compared to the consensus estimate of $651.94 million. During the same quarter in the prior year, the company earned $0.16 EPS. The company’s revenue was down 2.8% on a year-over-year basis. As a group, research analysts predict that Clarivate will post 0.64 EPS for the current year.
Clarivate Company Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
See Also
- Five stocks we like better than Clarivate
- Ride Out The Recession With These Dividend Kings
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What Are the U.K. Market Holidays? How to Invest and Trade
- MarketBeat Week in Review – 9/16 – 9/20
- What is the Dogs of the Dow Strategy? Overview and Examples
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.